vs

Side-by-side financial comparison of CorMedix Inc. (CRMD) and JBG SMITH Properties (JBGS). Click either name above to swap in a different company.

CorMedix Inc. is the larger business by last-quarter revenue ($128.6M vs $127.6M, roughly 1.0× JBG SMITH Properties).

CorMedix Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing novel therapeutic products for the prevention and treatment of infectious, inflammatory and cardiorenal diseases. Its lead candidate targets catheter-related bloodstream infections, serving critical care and chronic dialysis patient populations primarily across North America and European markets.

JBG SMITH Properties is a publicly traded real estate investment trust based in Bethesda, Maryland.

CRMD vs JBGS — Head-to-Head

Bigger by revenue
CRMD
CRMD
1.0× larger
CRMD
$128.6M
$127.6M
JBGS

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CRMD
CRMD
JBGS
JBGS
Revenue
$128.6M
$127.6M
Net Profit
$-23.0M
Gross Margin
83.4%
Operating Margin
46.0%
Net Margin
-18.1%
Revenue YoY
5.7%
Net Profit YoY
57.1%
EPS (diluted)
$0.20
$-0.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CRMD
CRMD
JBGS
JBGS
Q1 26
$127.6M
Q4 25
$128.6M
$127.6M
Q3 25
$104.3M
$123.9M
Q2 25
$39.7M
$126.5M
Q1 25
$39.1M
$120.7M
Q4 24
$130.8M
Q3 24
$136.0M
Q2 24
$135.3M
Net Profit
CRMD
CRMD
JBGS
JBGS
Q1 26
$-23.0M
Q4 25
$-45.5M
Q3 25
$108.6M
$-28.6M
Q2 25
$19.8M
$-19.2M
Q1 25
$20.6M
$-45.7M
Q4 24
$-59.9M
Q3 24
$-27.0M
Q2 24
$-24.4M
Gross Margin
CRMD
CRMD
JBGS
JBGS
Q1 26
Q4 25
83.4%
Q3 25
89.3%
Q2 25
95.3%
Q1 25
95.9%
Q4 24
Q3 24
Q2 24
Operating Margin
CRMD
CRMD
JBGS
JBGS
Q1 26
Q4 25
46.0%
-47.5%
Q3 25
49.2%
-27.5%
Q2 25
49.2%
-18.4%
Q1 25
51.5%
-44.7%
Q4 24
-53.6%
Q3 24
-22.4%
Q2 24
-24.3%
Net Margin
CRMD
CRMD
JBGS
JBGS
Q1 26
-18.1%
Q4 25
-35.7%
Q3 25
104.1%
-23.1%
Q2 25
49.9%
-15.2%
Q1 25
52.8%
-37.9%
Q4 24
-45.8%
Q3 24
-19.8%
Q2 24
-18.0%
EPS (diluted)
CRMD
CRMD
JBGS
JBGS
Q1 26
$-0.32
Q4 25
$0.20
$-0.76
Q3 25
$1.26
$-0.48
Q2 25
$0.28
$-0.29
Q1 25
$0.30
$-0.56
Q4 24
$-0.70
Q3 24
$-0.32
Q2 24
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CRMD
CRMD
JBGS
JBGS
Cash + ST InvestmentsLiquidity on hand
$148.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$405.3M
Total Assets
$826.1M
$4.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CRMD
CRMD
JBGS
JBGS
Q1 26
Q4 25
$148.5M
$75.3M
Q3 25
$55.7M
$64.4M
Q2 25
$190.7M
$61.4M
Q1 25
$77.5M
$81.3M
Q4 24
$145.8M
Q3 24
$137.0M
Q2 24
$163.5M
Stockholders' Equity
CRMD
CRMD
JBGS
JBGS
Q1 26
Q4 25
$405.3M
$1.2B
Q3 25
$374.1M
$1.2B
Q2 25
$220.6M
$1.3B
Q1 25
$114.9M
$1.6B
Q4 24
$1.8B
Q3 24
$1.9B
Q2 24
$2.0B
Total Assets
CRMD
CRMD
JBGS
JBGS
Q1 26
$4.3B
Q4 25
$826.1M
$4.4B
Q3 25
$750.9M
$4.4B
Q2 25
$252.6M
$4.5B
Q1 25
$149.6M
$4.7B
Q4 24
$5.0B
Q3 24
$5.2B
Q2 24
$5.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CRMD
CRMD
JBGS
JBGS
Operating Cash FlowLast quarter
$94.5M
Free Cash FlowOCF − Capex
$92.7M
FCF MarginFCF / Revenue
72.1%
Capex IntensityCapex / Revenue
1.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$172.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CRMD
CRMD
JBGS
JBGS
Q1 26
Q4 25
$94.5M
$73.3M
Q3 25
$30.9M
$8.9M
Q2 25
$30.0M
$18.8M
Q1 25
$19.7M
$12.9M
Q4 24
$129.4M
Q3 24
$26.4M
Q2 24
$23.8M
Free Cash Flow
CRMD
CRMD
JBGS
JBGS
Q1 26
Q4 25
$92.7M
Q3 25
$30.4M
Q2 25
$30.0M
Q1 25
$19.7M
Q4 24
Q3 24
Q2 24
FCF Margin
CRMD
CRMD
JBGS
JBGS
Q1 26
Q4 25
72.1%
Q3 25
29.1%
Q2 25
75.4%
Q1 25
50.5%
Q4 24
Q3 24
Q2 24
Capex Intensity
CRMD
CRMD
JBGS
JBGS
Q1 26
Q4 25
1.3%
Q3 25
0.5%
Q2 25
0.1%
Q1 25
0.0%
Q4 24
Q3 24
Q2 24
Cash Conversion
CRMD
CRMD
JBGS
JBGS
Q1 26
Q4 25
Q3 25
0.28×
Q2 25
1.51×
Q1 25
0.96×
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CRMD
CRMD

Acquisition Of Melinta$52.9M41%
Melinta Portfolio$45.5M35%
Other$18.6M14%
Contract Revenue$7.4M6%
BARDA Agreement$4.2M3%

JBGS
JBGS

Property rental$105.9M83%
Third-party real estate services, including reimbursements$17.2M13%
Other revenue$4.5M4%

Related Comparisons